The summary of stem cell clinical trials for retinal diseases - to treat retinal diseases

Animal studies have demonstrated the feasibility of delivering stem cells intranasally to treat retinal diseases like age-related macular degeneration (AMD), retinitis pigmentosa, diabetic retinopathy, and optic nerve damage. Intranasal delivery of mesenchymal stem cells has shown promise in bypassing the blood-brain barrier, allowing them to reach the retina more effectively. This non-invasive approach is believed to promote optic cell regeneration, reduce inflammation, and support retinal function. Researchers have observed migration of stem cells from the nasal cavity to the retina, where they can integrate and potentially replace damaged cells or provide trophic support. This method holds potential for advancing treatment options for RP patients in the near future.

----------------------------------------------------------------------------------------------------------------------
Contact us for any question about Stem Cell Treatment:

For more information and online order of AC STIM:

For more information and online order of StemActiv :

For information about V20 Light, please check:

For more information about OCU-ION: